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Introduction
To date, few studies have examined gray matter volume (GMV) abnormalities in pediatric anxiety disorders 1-3 in comparison to the larger literature in adults. 4, 5 These pediatric studies mostly focused on the medial temporal lobe including the amygdala and hippocampus. Importantly, disagreement exists with regards to directionality of effects and diagnostic specificity. While some studies in pediatric generalized anxiety disorders (GAD) report enlarged amygdala volumes for the patient relative to the healthy comparisons, 1 other studies in pediatric mixed samples, with GAD, separation anxiety disorder, and social phobia, report reduced amygdala volume in the patient group relative to comparisons. 3 In addition to alterations of medial temporal structures, more recent evidence implicates the anterior cingulate cortex (ACC) and the insula in adults with clinical anxiety. 5, 6 These findings, however, are also mixed. 5 Critical to the present work, no reports have yet documented alterations in these latter structures in pediatric anxiety samples.
Some of the inconsistency in findings can be related to unstable data in small samples, but also to genetic modulation. For instance, recent work highlights a modulation by the common BDNFVal 66 Met polymorphism of brain structures relevant to anxiety. [7] [8] [9] In this single nucleotide polymorphism (SNP, rs 6265), a critical amino acid valine-to-methionine substitution at codon 66 (Val66Met) has been shown to reduce activity-dependent secretion of BDNF 9 , a gene critically contributing to neuronal survival, migration, dendrite pruning and axonal growth. 10 Although BDNF is expressed throughout the cortex, high expression of this gene has been documented in the hippocampal formation, the prefrontal cortex and the ACC. 9, 11, 12 Notably, as a result of reduced BDNF expression in carriers with at least one Met allele, previous research has reported structural reductions of the amygdala, hippocampus, and ACC. 8, 13, 14 Furthermore, a recent functional imaging study in adolescents reported that the Val 66 Met polymorphism modulated amygdala and hippocampal function during emotional processing differentially in healthy and clinically-anxious adolescents. 15 These preliminary findings call for more work to further validate and better characterize associations among behavior, genetics, and brain structure in youth 16 , given the known role of the BDNF gene in development. 10, 17 Specifically in the context of anxiety, the potential influence of the BDNF Val 66 Met polymorphism on brain structure has not yet been examined in youth.
The goal of the present study is to examine in healthy and clinically anxious adolescents 1) GMV abnormalities in pediatric anxiety, including diagnostic specificity, and 2) the influence of BDNF genotype on the four brain structures most commonly implicated in anxiety disorders, the ACC, hippocampus, amygdala, and insula.
With regards to neuroanatomical differences between patients and healthy comparisons, we hypothesize that significant GMV alterations of the amygdala and hippocampus would be found in anxious relative to comparison adolescents based on previous structural findings in adolescents 3 and adults. 4 ***************Insert Table 1 about here please ****************
Methods

Participants
Thirty-nine adolescents diagnosed with an anxiety disorder and 63 healthy control adolescents underwent structural neuroimaging (Table1 Met (rs6265) genotyping was confirmed using a Taqman
Assay-on-Demand (Applied Biosystems, Foster City). Genotyping was performed according to the manufacturers protocol and genotype determined at end-point using an ABI 7900HT Sequence Detection System. Genotyping accuracy was determined empirically by duplicate genotyping of 25% of the samples selected randomly. The error rate was <0.005, and the completion rate was >0.95. These analyses showed 100% concordance across genotyping samples.
MRI data acquisition
Whole brain, high-resolution T1-weighted anatomical images were acquired on a 3 Tesla General Electric Signa Scanner (Waukesha, Wisconsin). For reasons independent of the present work, the Magnetic
Resonance Imaging (MRI) data were collected under two acquisition sequences, but on the same scanner. A first set of subjects (n=78) were scanned using an MPRAGE sequence consisting of 124 1. 
MRI processing
Prior to processing, data were examined for motion artefacts (ghosting, blurring) and anatomical abnormalities. In case of presence of such artefacts, data were excluded from the study sample. MRI data was preprocessed and analyzed using SPM8 (http://www.fil.ion.ucl.ac.uk/spm) and the Diffeomorphic Anatomical Registration using Exponentiated Lie algebra (DARTEL) toolbox. 23 The image origin was set at the anterior commissure (AC). Structural imaging data were segmented into white matter, gray matter, cerebral spinal fluid, skull, and soft tissue classes outside the brain. These images were inspected for the quality of segmentation before a study-specific brain template was created from all individual tissue-class images of each subject using iterative realignments. Data were then normalized and warped to an isotropic voxel size of 1.5 mm x 1.5mm x 1.5 mm.
Afterwards, the data were modulated by the Jacobian transformed tissue probability maps to obtain "volume" differences rather than "concentration" differences in gray matter. 24 Finally, data were checked for homogeneity across the sample, spatially normalized to the Montreal Neurologic Institute coordinate reference system and smoothed with a 10 mm (FWHM) isotropic Gaussian kernel.
Voxel-Based Morphometry (VBM) analysis
Based on strong a priori hypotheses of altered GMV volume in 4 regions associated with anxiety (amygdala, hippocampus, ACC, insula), an independent Region-Of-Interest (ROI) approach was adopted. We corrected for multiple comparisons using small volume correction (SVC) with a Gaussian random field threshold set at alpha α = .05, corrected and an extent of at least 10 contiguous voxels. Coordinates are reported in MNI space in mm [x, y, z]. All anatomical ROIs were created using standardized anatomical criteria 25, 26 on the MNI template, which were then applied to the normalized brain, at the group level. The ACC was hand-traced by two experts with 100% agreement, while the amygdala and hippocampal ROI were drawn using a semi-automated computerized system with intraclass correlations between 2 operators reaching .80 to .97 25 . Finally, the insula ROI was created using the Anatomical Automatic Labeling (AAL) system 26 ). To evaluate the potential impact of co-morbid depression on the findings, all analyses were rerun excluding the subjects with co-morbid MDD. In a third set of analyses, the potential impact of age, IQ, and sex was examined. To assess impact of symptom severity on the findings, regression analyses were conducted between the significant voxels and anxiety scores in the patient group. *************Insert Figure 1 about here please **************** *************Insert Table 2 about here please******************
Results
The MANCOVA revealed (1) a significant main effect of Group, and (2) a significant Group-by-Genotype interaction.
1) Neuroanatomic differences between patients and comparisons
Comparisons > Patients
Significant main effects of Group revealed reduced GMV in anxious adolescents relative to healthy adolescents in the right amygdala with a large effect size [28, 0, -18] (Figure 1 ). ****************** Insert Figure 2 about here please ******************
Patients > Comparisons
Significant volume increases were seen in two clusters in the left insula [-46, 12, -14] (F(1,94) *******************Insert Figure 3 about here please****************
Diagnostic Specificity
Amygdala and Hippocampus
To investigate to what extent diagnostic specificity may have contributed to the amygdala and hippocampal GMV reductions in anxious vs. healthy adolescents, post-hoc regression analyses were run on these findings coding each type of anxiety disorder (GAD, SAD, SP) as a dichotomous variable (present, absent). Of these, 16 subjects were non-SP GAD patients, 16 non-GAD SP patients and 6 comorbid GAD/SP. Of the SAD patients, 7 were co-morbid with GAD, 3 co-morbid with SP, 1 had all three comorbidities and 1 had no other diagnoses. 
Insula
To examine to what extent the GMV increases in the insula were driven by a specific diagnosis, regression analyses revealed that only one cluster in the right insula GMV [40, 30, -5] was associated with SP (t=2.25, p=.027) but not SAD (p=.312) or GAD (p=.464). No other associations with insula volume were found.
2) Impact of BDNF genotype: Group-by-Genotype interaction
Significant Group-by-Genotype interactions emerged in the right insula and right ACC ( Figure 3 , Figure 3 ).
In summary, the interaction of BDNF genotype and Group reflected (1) in the anxious group, smaller anterior and posterior insula volumes in the Met-carriers relative to Val/Val-homozygotes, and (2) no gene-related differences in the healthy group. Furthermore, within genotype, healthy Met-allele carriers had larger GMV in the posterior insula than patients with the Met allele.
Additional exploratory analyses
Effects of Age, IQ, or sex, anxiety symptom severity
To examine the potential influence of age, sex, IQ, or symptom severity on the current findings, main effects as well as interactions of these variables were examined in relation to group status and BDNF genotype. No significant main effects of any of these variables were detected (all p>.05). Importantly, no interactions with group or genotype were significant (all p>.05). Finally, regression analyses did not reveal a significant impact of severity of anxiety on the findings (all p>.05).
Psychiatric co-morbidity with MDD
To examine whether findings were driven by the patients with co-morbid MDD (n=8), the data were reanalyzed for all ROIs without these subjects. Findings remained significant for all comparisons, i.e., group effects on amygdala 
Discussion
This structural MRI study of anxious and healthy adolescents examined GMV in four regions, insula, ACC, amygdala, and hippocampus, all previously implicated in anxiety disorders. In addition, preliminary evidence for a role of the BDNF Val66Met polymorphism in the modulation of anxiety-related structural differences was explored.
Four main findings emerged. First, GMVs of the right amygdala and right anterior hippocampus were smaller in patients relative to comparisons, regardless of genotype. Second, additional regression analyses suggested some specificity of these GMV volume alterations to social phobia. Third, in contrast to the amygdala and hippocampus findings, insula volume was larger in the patient group relative to comparisons. Fourth, right-lateralized dACC and insula volume appeared to be modulated by the BDNF Val 66 Met polymorphism differentially in anxious adolescents and in comparisons. GMVs of the insula and ACC were smaller in the risk Met-allele carriers relative to the Val/Val homozygotes in the patient group, whereas comparisons showed the reverse effect.
To date, the few studies examining GMV abnormalities in pediatric anxiety report mixed results showing either GMV increases 1 or decreases 3 in patient relative to comparison groups. Moreover, these studies also differed in methodology using either VBM 3 or a manual-tracing approach 1 to measure volumetric changes. The first main finding of the present study revealed reduced volumes of the amygdala and hippocampus in the anxious group relative to the comparison group. These data are consistent with, and form an independent replication of, an earlier study in a smaller group of clinically anxious adolescents (N=17; mean age 13 yo), 3 extending prior work in adults. [27] [28] [29] The current data also demonstrate reduced GMV of the hippocampus, in addition to the amygdala, a finding not reported previously in adolescents. One possible factor that may have contributed to the mixed findings in previous studies is the potential impact of diagnostic specificity on GMV alterations. Indeed, while amygdala GMV reductions were found in a mixed sample of pediatric anxiety disorders (GAD, SAD, SP), 3 amygdala and superior temporal gyrus volumetric increases were found in pediatric post-traumatic stress disorder 30 and GAD. 1, 2 When diagnostic specificity was examined in relation to the current findings, the data suggested a specific relationship of the amygdala and hippocampal GMV reductions with SP, but not SAD or GAD. While these findings should be considered tentative, they suggest a contribution of SP to GMV reductions in the amygdala and hippocampus, at least in adolescents, and warrant replication in much larger samples of individuals with specific anxiety disorders.
The mechanisms that might produce structural abnormalities in the present study remain unclear.
However, prior findings of functional changes in adolescent mood and anxiety disorders might provide clues. 31, 32 For example, a recent study in adolescent bipolar disorder reported an inverse relationship between amygdala function during emotion processing and amygdala structure. 33 Such findings are consistent with the suggestion that over-activation of the amygdala reflects glutamatergic excitotoxicity, which would lead to volume loss over time. 34 However, no direct evidence of excitotoxicity exists in available research on pediatric anxiety disorders and more work is needed in this area. Moreover, existing work focuses selectively on the amygdala, raising questions on the degree to which similar or different mechanisms might also explain anxiety-related gray-matter-volume increases in other regions. 2, 35 Enhanced interoceptive awareness has been postulated in anxiety 6 and is a key function of the anterior insula. 36 Underlying mechanisms of such disturbance in interoceptive awareness could manifest as increases in insula volume. Of note, current findings in the amygdala and hippocampus were right-lateralized. Such an effect is certainly consistent with prior reports of structural 1 and functional 32 perturbations in the right but not left amygdala associated with anxiety. Although left-lateral alterations in the current study were present at a subthreshold level, the current data are also in-line with previous reports of larger perturbations in volume on the right relative to the left side in other structures in pediatric anxiety. 2 These findings lend further support to laterality theories of emotion, which posit a special role of the right side of the brain in the processing of negative emotions. 37 The third main finding suggests that BDNF genotype modulates GMV in the dorsal portion of the ACC (dACC) and insula differently in clinically anxious and healthy youth. Specifically, the regional selectivity of the dACC and insula suggest these regions may be particularly sensitive to the action of BDNF in adolescence, in a way that may harbor risk for anxiety. Regarding the dACC, studies in several cohorts of anxiety disorders (SP, specific phobia, GAD) document abnormalities in dACC function. 32 The anterior insula is considered to be a primary contributor to anxiety in adults. 6 By comparison, functional neuroimaging studies of anxiety in adolescents have to date focused primarily on the amygdala. 15 The present finding further highlights the relevance of extending this focus to the insula in pediatric studies. Noteworthy, the Val 66 Met polymorphism modulated the volume of both the anterior and posterior insula regions in anxious, but not healthy adolescents. This functional link between the two insula regions is particularly relevant to anxiety, based on the hypersensitivity of anxious individuals to bodily signals. 6 The posterior insula integrates interoceptive signals, 41, 42 which in turn are carried to the anterior insula for integration, a process that may be excessively reinforced in anxiety. 36 Collectively, these preliminary findings implicate BDNF in modulation of dACC and insula GMV in anxious adolescents. Such findings raise questions regarding the specific aspects of anxiety that are influenced by this genetic modulation, and the extent to which this modulation is specific to the adolescent period. Such genetic effect might be exploited therapeutically in the future, given recent evidence that a variant of the BDNF gene is associated with improved therapeutic outcome with serotonin reuptake inhibitors in anxious adult patients. 43 Finally, this pediatric study may inform on developmental aspects of gene-brain associations. Our analyses failed to detect a genotypic modulation of amygdala or hippocampal volumes in healthy adolescents, in contrast to previous work in healthy adults. 8, 13 Yet, this discrepant finding is congruent with the study by Toro et al. 18 who found no significant impact of the Val
66
Met polymorphism on amygdala or hippocampal volume in 331 healthy adolescents. Similarly, Casey et al. 44 reported, in healthy children, the absence of BDNF genotypic effect on amygdala volume but reported a trend towards smaller hippocampal volume in the Met-allele carriers compared to the Val/Val homozygotes. Taken together, these studies suggest that the morphometry of the amygdala and hippocampus might start to be differentially affected by BDNF gene variants only in adulthood. This maturational change might be related to the ontogenic trajectory of BDNF levels, 35 or to changes in cellular receptivity to BDNF action with age. The fact that BDNF genotype affects brain structure in adolescents with psychopathology but not in healthy youths may be related to neurochemical changes associated with the pathology. For example, perturbations in BDNF levels may contribute to structural abnormalities in psychopathology by influencing critical protein (reelin)
or receptor (TrkB) activity fluctuations in anxiety that further influences brain developmental processes such as neuronal differentiation or cortical lamination. 12 As a result of altered BDNF expression, possibly because of change in glutamate signaling, 12 individuals with anxiety or other psychopathology would then demonstrate perturbed structural neural development during the adolescent period. More research is needed to determine the influence of these molecular processes on brain maturation. However, given the absence of findings in several independent studies, 18, 44 an alternative explanation for the absence of an influence of the Val66Met polymorphism on healthy youths could be the potential presence of false positives in this prior line of work in adults. In any case, this study stresses the importance to understand the functional and clinical significance of the developmental effect of BDNF variant on brain morphometry, particularly in relation to the onset of psychiatric disorders.
Some limitations require consideration. One limitation concerns the relatively small number of subjects in the patient BDNF Met group (N=17). This limitation is mitigated by a few factors. Importantly, a power analysis revealed an acceptable level of power to detect reliable differences in the Group by Genotype interaction. In addition, the current study includes a relatively large number of patients, coupled with the fact that all patients were seeking treatment for acute, severe anxiety symptoms, and none were on medications. Medication-free, acutely ill subjects are difficult to recruit. In fact, small sample sizes have been the rule in prior research with such samples.
Second, candidate gene studies need to be interpreted with caution. The association between a disorder and a gene is complex due to a variety of possible influences including gene-gene and gene-environment interactions. Thus, replication in large samples is necessary to confirm findings and gain insight into the contribution of a gene to psychopathology. A third limitation relates to the use of two different scanning acquisition sequences. This concern is moderated by the fact that all groups were well-matched on scan sequence, and findings did not differ between scan sequences. Finally, we did not assess parental psychopathology, which was beyond the scope of the current study. However, future studies should include such measures as they could inform neurobiological predictors of atrisk individuals.
In summary, the current findings suggest that GMV reductions in the amygdala and anterior hippocampus are already present in adolescents with an anxiety disorder. Importantly, this is the first study to show in adolescents, that dACC and insula volume are modulated by the BDNF Val 66 Met polymorphism, thus extending prior structural work in adults 8, 13 and functional work in adolescents.
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Note: * for easier comparison, MNI coordinates were converted to Talairach coordinates using WFU Pickatlas. 
